Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 151691000087113 | GamaSTAN 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 151701000087113 | Ig GamaSTAN Grif | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 151711000087110 | GamaSTAN 15 to 18 percent solution for injection Grifols Therapeutics Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| GamaSTAN 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| GamaSTAN 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug) | a pour principe actif (attribut) | immunoglobuline humaine normale (substance) | true | Inferred relationship | Some | 1 | |
| GamaSTAN 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug) | est un(e) (attribut) | Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| GamaSTAN 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug) | Has supplier | Grifols Therapeutics Inc. (supplier) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR